Effective September 17, 2014, ALL BUTALBITAL CONTAINING PRODUCTS (Fioricet, Bupap, Esgic, etc.) are now SCHEDULE III CONTROLLED SUBSTANCES in the Commonwealth of Kentucky.
Prescriptions for butalbital containing products must be reported to KASPER.
A prescriber without a DEA license cannot write or issue a prescription for a butalbital containing product. In addition, any remaining refills on a butalbital containing product prescription issued by a prescriber without a valid DEA license may NOT be dispensed.
If a physician prescriber issued a prescription for a butalbital containing product with refills AND it has not been more than 6 months from the date written, it may be refilled.
APRNs who have a valid DEA Number may prescribe butalbital containing products, but they are not permitted to write refills on those prescriptions because APRNs are not permitted to write refills on Schedule III medications.